Oral desipramine and topical lidocaine for vulvodynia: A randomized controlled trial

Obstetrics and Gynecology

Volumn 116, Issue 3, 2010, Pages 583-593

  Foster, David C ^a   Kotok, Merrill Beth ^a   Huang, Li Shan ^a   Watts, Arthur ^a   Oakes, David ^a   Howard, Fred M ^a   Poleshuck, Ellen L ^a   Stodgell, Chris J ^a   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; LIDOCAINE; PARACETAMOL; PLACEBO; LOCAL ANESTHETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MCGILL PAIN QUESTIONNAIRE; MONOTHERAPY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL SATISFACTION; SIDE EFFECT; TACHYCARDIA; TAMPON; TREATMENT DURATION; VULVODYNIA; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ANESTHETICS, LOCAL; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DESIPRAMINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; TREATMENT OUTCOME; VULVODYNIA; YOUNG ADULT;

EID: 77957266378     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e9e0ab     Document Type: Article

References (26)

1. Updike GM, Wiesenfeld HC Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol 2005;193:1404-9.
2. Yalcin I, Tessier LH, Petit-Demoulière N, Doridot S, Hein L, Freund-Mercier MJ, et al. Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain. Neurobiol Dis 2009;33:386-94.
3. Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, et al. The role of sodium channels in chronic inflammatory and neuropathic pain [review]. J Pain 2006;7(5 suppl 3):S1-29.
4. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104:126-33.
5. Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 2004;8:129-33.
6. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuro-pathic pain: evidence-based recommendations. Pain 2007;132: 237-51.
7. Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001;98:45-51.
8. Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, et al. The tampon test for vulvodynia treatment outcome research: reliability, construct validity, and responsiveness. Obstet Gynecol 2009;113:825-32.
9. Curnow JS, Barron L, Morrison G, Sergeant P. Vulval algesi-ometer. Med Biol Eng Comput 1996;34:266-9.
10. Eva LJ, Reid WM, MacLean AB, Morrison GD. Assessment of response to treatment in vulvar vestibulitis syndrome by means of the vulvar algesiometer. Am J Obstet Gynecol 1999;181: 99-102.
11. Dotson RM. Clinical neurophysiology laboratory tests to assess the nociceptive system in humans. J Clin Neurophysiol 1997; 14:32-45.
12. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23: 129-38.
13. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7.
14. Galer BS, Jensen MP. Development and preliminary valida-tion of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332-8.
15. McNair DM, Lorr M. An analysis if mood in neurotics. J Abnorm Psychol 1964;69:620-7.
16. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
17. Hudson W, Harrison D, Crosscup P. A short-form scale to measure sexual discord in dyadic relationships. J Sex Res 1981;17:157-74.
18. Dmitrienko A, Wiens BL, Tamhane AC, Wang X. Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives [published erratum appears in Stat Med 2008;27:3452]. Stat Med 2007;26:2465-78.
19. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
20. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lido-caine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003;102:84-7.
21. Fillingim RB, Price DD. What is controlled for in placebo-controlled trials? Mayo Clin Proc 2005;80:1119-21.
22. Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol 2008;112:231-7.
23. Haefner HK, Collins ME, Davis GD, Edwards L, Foster, DC, Hartmann ED, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005;9:40-51.
24. Bergeron S, Binik YM, Khalifé S, Pagidas K, Glazer HI, Meana M, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspa-reunia resulting from vulvar vestibulitis. Pain 2001;91: 297-306.
25. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidi-mensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
26. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 2009;9:1.